Global Custom Market Research Reports Provider Company

phone

Global Blood Therapeutics Inc (GBT) - Financial and Strategic SWOT Analysis Review

  • Published Date: 13 Nov 2017
  • Number of Pages: 25
  • Category: Healthcare and Medical
  • Country: United States of America
Summary

Global Blood Therapeutics Inc (GBT) is a clinical-stage biopharmaceutical company that discovers, develops and commercializes novel oral medicines for the treatment of grievous blood-based disorders. The companys lead drug candidate GBT440 is an oral, small molecule drug for the treatment of sickle cell disease (SCD) is in Phase II clinical trial statge. Its GBT440 is a hemoglobin modifier which targets the mechanism of red blood cell sickling for the treatment of SCD. GBTs pipeline also includes an oral kallikrein inhibitor to prevent hereditary angioedema (HAE) attacks. The company also develops therapies which are in preclinical and preliminary clinical stage for the treatment of for acute and chronic hypoxemic pulmonary disorders such as idiopathic pulmonary fibrosis (IPF) and acute respiratory distress syndrome (ARDS). It offers chemical and biological mechanisms of blood-based disorders. GBT is headquartered in South San Francisco, California, the US.

Global Blood Therapeutics Inc Key Recent Developments

Nov 02,2017: Global Blood Therapeutics Reports Recent Business Progress and Provides Third Quarter 2017 Financial Results
Sep 06,2017: Global Blood Therapeutics To Convene Sickle Cell Disease Influencers at Annual Sickle Cell Disease Therapeutics Conference
Aug 07,2017: Global Blood Therapeutics Reports Recent Business Progress and Provides Second Quarter 2017 Financial Results
May 01,2017: Global Blood Therapeutics Reports Recent Business Progress and Provides First Quarter 2017 Financial Results
Mar 13,2017: Global Blood Therapeutics Reports Recent Business Progress and Fourth Quarter and Year-End 2016 Financial Results

This comprehensive SWOT profile of Global Blood Therapeutics Inc provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalDatas Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, GlobalDatas highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Global Blood Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,



- Business description A detailed description of the companys operations and business divisions.

- Corporate strategy Analysts summarization of the companys business strategy.

- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.

- Company history Progression of key events associated with the company.

- Major products and services A list of major products, services and brands of the company.

- Key competitors A list of key competitors to the company.

- Key employees A list of the key executives of the company.

- Executive biographies A brief Summary of the executives employment history.

- Key operational heads A list of personnel heading key departments/functions.

- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.



Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,



You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.



Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.



Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.



Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.



Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Publisher Name : GlobalData
Table of Contents


Section 1 - About the Company



Global Blood Therapeutics Inc - Key Information

Global Blood Therapeutics Inc - Overview

Global Blood Therapeutics Inc - Key Employees

Global Blood Therapeutics Inc - Key Employee Biographies

Global Blood Therapeutics Inc - Key Operational Heads

Global Blood Therapeutics Inc - Major Products and Services

Global Blood Therapeutics Inc - History

Global Blood Therapeutics Inc - Company Statement

Global Blood Therapeutics Inc - Locations And Subsidiaries

Global Blood Therapeutics Inc - Key Manufacturing facilities

Head Office

Other Locations & Subsidiaries



Section 2 - Company Analysis



Global Blood Therapeutics Inc - Business Description

Global Blood Therapeutics Inc - Corporate Strategy

Global Blood Therapeutics Inc - SWOT Analysis

SWOT Analysis - Overview

Global Blood Therapeutics Inc - Strengths

Global Blood Therapeutics Inc - Weaknesses

Global Blood Therapeutics Inc - Opportunities

Global Blood Therapeutics Inc - Threats

Global Blood Therapeutics Inc - Key Competitors



Section 3 - Company Financial Performance Charts



Global Blood Therapeutics Inc - Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts



Section 4 - Appendix



Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer





Note*: Some sections may be missing if data is unavailable for the company

List Of Tables




Global Blood Therapeutics Inc, Key Information

Global Blood Therapeutics Inc, Key Ratios

Global Blood Therapeutics Inc, Share Data

Global Blood Therapeutics Inc, Major Products and Services

Global Blood Therapeutics Inc, History

Global Blood Therapeutics Inc, Key Employees

Global Blood Therapeutics Inc, Key Employee Biographies

Global Blood Therapeutics Inc, Key Operational Heads

Global Blood Therapeutics Inc, Other Locations

Global Blood Therapeutics Inc, Subsidiaries

Global Blood Therapeutics Inc, Key Manufacturing facilities

Global Blood Therapeutics Inc, Key Competitors

Global Blood Therapeutics Inc, SWOT Analysis

Global Blood Therapeutics Inc, Ratios based on current share price

Global Blood Therapeutics Inc, Annual Ratios

Global Blood Therapeutics Inc, Interim Ratios

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List Of Figures




Global Blood Therapeutics Inc, Performance Chart

Global Blood Therapeutics Inc, Ratio Charts

In this report, the global Zipper market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at

View Report

In this report, the global Work Apparel market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing

View Report

In this report, the global Womens Handbags market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports